Intuitive Surgical, Inc. $ISRG Shares Acquired by Signature Estate & Investment Advisors LLC

Signature Estate & Investment Advisors LLC lifted its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 85.0% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,426 shares of the medical equipment provider’s stock after purchasing an additional 655 shares during the period. Signature Estate & Investment Advisors LLC’s holdings in Intuitive Surgical were worth $775,000 as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in ISRG. Chilton Capital Management LLC increased its stake in shares of Intuitive Surgical by 614.3% in the first quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider’s stock worth $25,000 after buying an additional 43 shares during the last quarter. Elite Financial Inc. bought a new stake in shares of Intuitive Surgical in the first quarter worth $26,000. LFA Lugano Financial Advisors SA bought a new stake in shares of Intuitive Surgical in the first quarter worth $30,000. TD Capital Management LLC increased its stake in shares of Intuitive Surgical by 300.0% in the first quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider’s stock worth $30,000 after buying an additional 45 shares during the last quarter. Finally, 1248 Management LLC bought a new stake in shares of Intuitive Surgical in the first quarter worth $30,000. 83.64% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several research firms have weighed in on ISRG. Wall Street Zen lowered shares of Intuitive Surgical from a “buy” rating to a “hold” rating in a research note on Saturday. The Goldman Sachs Group lowered their target price on shares of Intuitive Surgical from $621.00 to $567.00 and set a “buy” rating for the company in a research note on Wednesday, October 1st. Wells Fargo & Company boosted their target price on shares of Intuitive Surgical from $559.00 to $599.00 and gave the company an “overweight” rating in a research note on Wednesday, July 23rd. Weiss Ratings reiterated a “hold (c+)” rating on shares of Intuitive Surgical in a research note on Wednesday, October 8th. Finally, Deutsche Bank Aktiengesellschaft reiterated a “sell” rating on shares of Intuitive Surgical in a research note on Friday, August 22nd. Fourteen investment analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $580.29.

Insider Buying and Selling

In related news, EVP Myriam Curet sold 4,500 shares of the company’s stock in a transaction dated Friday, July 25th. The shares were sold at an average price of $492.48, for a total value of $2,216,160.00. Following the completion of the sale, the executive vice president owned 353 shares of the company’s stock, valued at $173,845.44. This represents a 92.73% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Amy L. Ladd sold 335 shares of the company’s stock in a transaction dated Thursday, September 4th. The stock was sold at an average price of $440.69, for a total transaction of $147,631.15. Following the completion of the sale, the director directly owned 739 shares of the company’s stock, valued at $325,669.91. The trade was a 31.19% decrease in their position. The disclosure for this sale can be found here. Insiders sold 45,224 shares of company stock valued at $21,716,492 over the last 90 days. 0.70% of the stock is currently owned by company insiders.

Intuitive Surgical Stock Performance

Shares of ISRG opened at $446.13 on Monday. Intuitive Surgical, Inc. has a 1 year low of $425.00 and a 1 year high of $616.00. The company has a market cap of $159.93 billion, a price-to-earnings ratio of 62.22, a price-to-earnings-growth ratio of 4.69 and a beta of 1.61. The firm has a fifty day moving average of $454.97 and a 200-day moving average of $495.76.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.93 by $0.26. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The company had revenue of $2.44 billion during the quarter, compared to the consensus estimate of $2.35 billion. During the same quarter in the previous year, the company posted $1.78 earnings per share. The company’s revenue for the quarter was up 21.4% compared to the same quarter last year. Analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.